Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080440 | SCV000112342 | pathogenic | not provided | 2017-03-27 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000080440 | SCV002018621 | pathogenic | not provided | 2023-06-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003512012 | SCV004298933 | pathogenic | Duchenne muscular dystrophy | 2023-08-08 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with Duchenne muscular dystrophy (PMID: 19937601). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 94455). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser429*) in the DMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DMD are known to be pathogenic (PMID: 16770791, 25007885). |